About Riobliss Life Sciences Private Limited
Data last updated:
Riobliss Life Sciences Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 03 March 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Uttar Pradesh, under CIN U24299UP2020PTC127609. Its GSTIN is 09AAKCR1196F2Z3 (Uttar Pradesh). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1.5 Lakh. It is led by directors Antima Singh and Swarna Prabha Asha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A – 163 Xu2, Greater Noida, Uttar Pradesh, India – 201308.
As per the financials filed for FY 2025, the company reported a revenue of ₹54.04 Lakh, a growth of 48% compared to the previous year. For the same year it recorded a net profit of ₹42,433 (net margin 0.8%) and EBITDA of ₹1.23 Lakh (EBITDA margin 2.3%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years.
The company has about 4 employees on its provident fund (EPFO) records.
For more details, the company can be reached via its website riobliss.in.
Company details
Contact details
Riobliss Life Sciences Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its website is riobliss.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressA – 163 Xu2, Greater Noida, Uttar Pradesh, India – 201308
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Riobliss Life Sciences Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Riobliss Life Sciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Riobliss Life Sciences Private Limited, buy the company report.
Financials of Riobliss Life Sciences Private Limited
FY 2025 filings availableRiobliss Life Sciences Private Limited reported revenue of ₹54.04 Lakh (up 48% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 54% over three years, including 48% growth in the latest year. EBITDA rose 158% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.23 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹42,433 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.3% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Riobliss Life Sciences Private Limited, buy the company report.
Board of directors of Riobliss Life Sciences Private Limited
Riobliss Life Sciences has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Antima Singh | Director | 03 Mar 2020 | 6 Years 7 Months | Current |
| Swarna Prabha Asha | Additional Director | 19 Jun 2022 | 4 Years 4 Months | Current |
Peer comparison
Riobliss Life Sciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Gitvin Remedies (GR) Private Limited | ₹54.53 Lakh (FY 2025) | -36.0% | Ahmedabad, Gujarat, India | |||
| Qualis Health Care Formulations Private Limited | ₹54.28 Lakh (FY 2017) | -25.0% | Kozhikode, Kerala, India | |||
| Riobliss Life Sciences Private Limited this company | ₹54.04 Lakh (FY 2025) | ₹42,433 | 0.8% | 48.0% | 4 | Greater Noida, Uttar Pradesh, India |
| Licot Formulations Private Limited | ₹53.94 Lakh (FY 2024) | -41.0% | Srinagar, Jammu and Kashmir, India | |||
| Catch Formulations Private Limited | ₹53.86 Lakh (FY 2018) | 165.0% | Patna, Bihar, India |
To see the full peer comparison of Riobliss Life Sciences Private Limited, buy the company report.
Auditor
Riobliss Life Sciences Private Limited is audited by R CHOLA & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| R CHOLA & CO | FY 2022 | 005201C |
Shareholding
The shareholding of Riobliss Life Sciences Private Limited is on record for 2 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Riobliss Life Sciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Riobliss Life Sciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Riobliss Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Riobliss Life Sciences Private Limited has a workforce of 4 employees on its EPFO records as of Apr 08, 2024, across 1 active EPFO establishment.
GST
Riobliss Life Sciences has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAKCR1196F2Z3 | Uttar Pradesh | Active | 30 Aug 2022 |
To see the full GST registrations and return filing status of Riobliss Life Sciences Private Limited, buy the company report.
Recent activity
Riobliss Life Sciences Private Limited has 4 board changes on record since 2020: 2 appointments and 2 cessations. The latest: Ankita Pandey ceased to be Director on 19 Jun 2022.
Frequently asked questions
Riobliss Life Sciences is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 03 March 2020 (6+ years old) and is registered under CIN U24299UP2020PTC127609.
Riobliss Life Sciences has 2 current directors:
- Antima Singh - Director
- Swarna Prabha Asha - Additional Director
The latest financial statements of Riobliss Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2020 are in the company report.
The GSTIN of Riobliss Life Sciences is 09AAKCR1196F2Z3, registered in Uttar Pradesh. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Riobliss Life Sciences is U24299UP2020PTC127609. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Riobliss Life Sciences was incorporated on 03 March 2020, making it 6+ years old. It is registered with the Registrar of Companies, Uttar Pradesh.
The peers of Riobliss Life Sciences by revenue are Gitvin Remedies (GR) Private Limited, Qualis Health Care Formulations Private Limited, Licot Formulations Private Limited, Catch Formulations Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Ankita Pandey ceased to be Director on 19 Jun 2022. Suman Tripathi ceased to be Director on 19 Jun 2022. Swarna Prabha Asha was appointed as Additional Director on 19 Jun 2022. Riobliss Life Sciences has 4 board changes on record in total.
Riobliss Life Sciences can be reached through the website riobliss.in. Its registered office is in Greater Noida, Uttar Pradesh, India.
The registered office of Riobliss Life Sciences is at A – 163 Xu2, Greater Noida, Uttar Pradesh, India – 201308.
Riobliss Life Sciences operates in the pharma industry, in the drug formulation and development segment.